Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques

Virology

Volumn 374, Issue 2, 2008, Pages 528-534

  Kent, Stephen J ^a   De Rose, Robert ^a   Mokhonov, Vlad V ^d   Mokhonova, Ekaterina I ^d   Fernandez, Caroline S ^a   Alcantara, Sheilajen ^a   Rollman, Erik ^a   Mason, Rosemarie D ^a   Loh, Liyen ^a   Peut, Viv ^a   Reece, Jeanette C ^a   Wang, Xiang Ju ^d   Wilson, Kim M ^b   Suhrbier, Andreas ^c   Khromykh, Alexander ^d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b National Serology Reference Laboratory   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

HIV; Kunjin; Macaca nemestrina; Macaques; SIV; Vaccines

Indexed keywords

GAG PROTEIN; POL PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC ENGINEERING; IMMUNIZATION; KUNJIN VIRUS; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS LIKE AGENT;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; FUSION PROTEINS, GAG-POL; GENETIC ENGINEERING; HIV-1; LYMPHOCYTE ACTIVATION; MACACA NEMESTRINA; REPLICON; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VACCINES, SYNTHETIC; WEST NILE VIRUS;

ANIMALIA; FLAVIVIRUS; MACACA; MACACA NEMESTRINA; MUS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 42649098581     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.01.006     Document Type: Article

References (35)

1. HIV vaccine failure prompts Merck to halt trial. Nature 449 7161 (2007) 390
2. Almeida J.R., Price D.A., Papagno L., Arkoub Z.A., Sauce D., Bornstein E., Asher T.E., Samri A., Schnuriger A., Theodorou I., Costagliola D., Rouzioux C., Agut H., Marcelin A.G., Douek D., Autran B., and Appay V. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204 10 (2007) 2473-2485
3. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S., Staprans S., Montefiori D., Xu Y., Herndon J., Wyatt L., Candido M., Kozyr N., Earl P., Smith J., Ma H., Grimm B., Hulsey M., Miller J., McClure H., McNicholl J., Moss B., and Robinson H.L. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292 (2001) 69-74
4. Anraku I., Harvey T.J., Linedale R., Gardner J., Harrich D., Suhrbier A., and Khromykh A.A. Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity. J. Virol. 76 8 (2002) 3791-3799
5. Appanna R., Huat T.L., See L.L., Tan P.L., Vadivelu J., and Devi S. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin. Vaccine Immunol. 14 8 (2007) 969-977
6. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., Bilska M., Craiu A., Zheng X.X., Krivulka G.R., Beaudry K., Lifton M.A., Nickerson C.E., Trigona W.L., Punt K., Freed D.C., Guan L., Dubey S., Casimiro D., Simon A., Davies M.E., Chastain M., Strom T.B., Gelman R.S., Montefiori D.C., and Lewis M.G. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290 5491 (2000) 486-492
7. Batten C.J., Rose R.D., Wilson K.M., Agy M.B., Chea S., Stratov I., Montefiori D.C., and Kent S.J. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model. AIDS Res. Hum. Retrovir. 22 6 (2006) 580-588
8. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., Lederman M.M., Benito J.M., Goepfert P.A., Connors M., Roederer M., and Koup R.A. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107 12 (2006) 4781-4789
9. Cohen J. HIV/AIDS. Vaccine results lose significance under scrutiny. Science 299 5612 (2003) 1495
10. Dale C.J., De Rose R., Stratov I., Chea S., Montefiori D., Thomson S.A., Ramshaw I.A., Coupar B.E., Boyle D.B., Law M., and Kent S.J. Efficacy of DNA and fowlpoxvirus prime/boost vaccines for simian/human immunodeficiency virus. J. Virol. 78 (2004) 13819-13828
11. Davis N.L., Caley I.J., Brown K.W., Betts M.R., Irlbeck D.M., McGrath K.M., Connell M.J., Montefiori D.C., Frelinger J.A., Swanstrom R., Johnson P.R., and Johnston R.E. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J. Virol. 74 1 (2000) 371-378
12. De Rose R., Batten C.J., Smith M.Z., Fernandez C.S., Peut V., Thomson S., Ramshaw I.A., Coupar B.E., Boyle D.B., Venturi V., Davenport M.P., and Kent S.J. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. J. Virol. 81 1 (2007) 292-300
13. Evans D.T., Bricker J.E., Sanford H.B., Lang S., Carville A., Richardson B.A., Piatak Jr. M., Lifson J.D., Mansfield K.G., and Desrosiers R.C. Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239. J. Virol. 79 12 (2005) 7707-7720
14. Fernandez C.S., Smith M.Z., Batten C.J., De Rose R., Reece J.C., Rollman E., Venturi V., Davenport M.P., and Kent S.J. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants. J. Virol. 81 8 (2007) 4137-4144
15. Goonetilleke N., Moore S., Dally L., Winstone N., Cebere I., Mahmoud A., Pinheiro S., Gillespie G., Brown D., Loach V., Roberts J., Guimaraes-Walker A., Hayes P., Loughran K., Smith C., De Bont J., Verlinde C., Vooijs D., Schmidt C., Boaz M., Gilmour J., Fast P., Dorrell L., Hanke T., and McMichael A.J. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J. Virol. 80 10 (2006) 4717-4728
16. Gupta S., Zhou F., Greer C.E., Legg H., Tang T., Luciw P., zur Megede J., Barnett S.W., Donnelly J.J., O'Hagan D.T., Polo J.M., and Vajdy M. Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles. AIDS Res. Hum. Retrovir. 22 10 (2006) 993-997
17. Hall R.A., Nisbet D.J., Pham K.B., Pyke A.T., Smith G.A., and Khromykh A.A. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus. Proc. Natl. Acad. Sci. U. S. A. 100 18 (2003) 10460-10464
18. Harvey T.J., Anraku I., Linedale R., Harrich D., Mackenzie J., Suhrbier A., and Khromykh A.A. Kunjin virus replicon vectors for human immunodeficiency virus vaccine development. J. Virol. 77 14 (2003) 7796-7803
19. Harvey T.J., Liu W.J., Wang X.J., Linedale R., Jacobs M., Davidson A., Le T.T., Anraku I., Suhrbier A., Shi P.Y., and Khromykh A.A. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 78 1 (2004) 531-538
20. Herd K.A., Harvey T., Khromykh A.A., and Tindle R.W. Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour. Virology 319 2 (2004) 237-248
21. Hill A.B., Mullbacher A., Parrish C., Coia G., Westaway E.G., and Blanden R.V. Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses. J. Gen. Virol. 73 Pt 5 (1992) 1115-1123
22. Johnston M.I., and Fauci A.S. An HIV vaccine-evolving concepts. N. Engl. J. Med. 356 20 (2007) 2073-2081
23. Kaur A., Sanford H.B., Garry D., Lang S., Klumpp S.A., Watanabe D., Bronson R.T., Lifson J.D., Rosati M., Pavlakis G.N., Felber B.K., Knipe D.M., and Desrosiers R.C. Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus. Virology 357 2 (2007) 199-214
24. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., Reddy S., de Pierres C., Mncube Z., Mkhwanazi N., Bishop K., van der Stok M., Nair K., Khan N., Crawford H., Payne R., Leslie A., Prado J., Prendergast A., Frater J., McCarthy N., Brander C., Learn G.H., Nickle D., Rousseau C., Coovadia H., Mullins J.I., Heckerman D., Walker B.D., and Goulder P. CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13 1 (2007) 46-53
25. Koff W.C., Johnson P.R., Watkins D.I., Burton D.R., Lifson J.D., Hasenkrug K.J., McDermott A.B., Schultz A., Zamb T.J., Boyle R., and Desrosiers R.C. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 7 1 (2006) 19-23
26. Kumar P., Krishna V.D., Sulochana P., Nirmala G., Haridattatreya M., and Satchidanandam V. Cell-mediated immune responses in healthy children with a history of subclinical infection with Japanese encephalitis virus: analysis of CD4+ and CD8+ T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J. Gen. Virol. 85 Pt 2 (2004) 471-482
27. Rollman E., Smith M.Z., Brooks A.G., Purcell D.F., Zuber B., Ramshaw I.A., and Kent S.J. Killing kinetics of simian immunodeficiency virus-specific CD8+ T cells: implications for HIV vaccine strategies. J. Immunol. 179 7 (2007) 4571-4579
28. Sacha J.B., Chung C., Rakasz E.G., Spencer S.P., Jonas A.K., Bean A.T., Lee W., Burwitz B.J., Stephany J.J., Loffredo J.T., Allison D.B., Adnan S., Hoji A., Wilson N.A., Friedrich T.C., Lifson J.D., Yang O.O., and Watkins D.I. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 178 5 (2007) 2746-2754
29. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., and Reimann K.A. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 5403 (1999) 857-860
30. Simmons C.P., Dong T., Chau N.V., Dung N.T., Chau T.N., Thao le T.T., Dung N.T., Hien T.T., Rowland-Jones S., and Farrar J. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J. Virol. 79 9 (2005) 5665-5675
31. Smith M.Z., Dale C.J., De Rose R., Stratov I., Fernandez C.S., Brooks A.G., Weinfurter J.T., Krebs K., Riek C., Watkins D.I., O'Connor D.H., and Kent S.J. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes. J. Virol. 79 (2005) 684-695
32. Smith M.Z., Fernandez C.S., Chung A., Dale C.J., De Rose R., Lin J., Brooks A.G., Krebs K.C., Watkins D.I., O'Connor D.H., Davenport M.P., and Kent S.J. The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion. J. Med. Primatol. 34 5-6 (2005) 282-293
33. Sun Y., Schmitz J.E., Acierno P.M., Santra S., Subbramanian R.A., Barouch D.H., Gorgone D.A., Lifton M.A., Beaudry K.R., Manson K., Philippon V., Xu L., Maecker H.T., Mascola J.R., Panicali D., Nabel G.J., and Letvin N.L. Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytes. J. Immunol. 174 8 (2005) 4753-4760
34. Wilson N.A., Reed J., Napoe G.S., Piaskowski S., Szymanski A., Furlott J., Gonzalez E.J., Yant L.J., Maness N.J., May G.E., Soma T., Reynolds M.R., Rakasz E., Rudersdorf R., McDermott A.B., O'Connor D.H., Friedrich T.C., Allison D.B., Patki A., Picker L.J., Burton D.R., Lin J., Huang L., Patel D., Heindecker G., Fan J., Citron M., Horton M., Wang F., Liang X., Shiver J.W., Casimiro D.R., and Watkins D.I. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol. 80 12 (2006) 5875-5885
35. Xu R., Srivastava I.K., Greer C.E., Zarkikh I., Kraft Z., Kuller L., Polo J.M., Barnett S.W., and Stamatatos L. Characterization of immune responses elicited in macaques immunized sequentially with chimeric VEE/SIN alphavirus replicon particles expressing SIVGag and/or HIVEnv and with recombinant HIVgp140Env protein. AIDS Res. Hum. Retrovir. 22 10 (2006) 1022-1030